{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:03:14Z","timestamp":1791187394212,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.02.033","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T00:42:21Z","timestamp":1366159341000},"page":"A1-A20","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S1","title":["New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain"],"prefix":"10.1016","volume":"31","author":[{"given":"Gregory A.","family":"Poland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Treanor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Maraskovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Luke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma M.A.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2013.02.033_bib0005","first-page":"16","article-title":"Influenza: the once and future pandemic","volume":"125","author":"Taubenberger","year":"2010","journal-title":"Public Health Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.033_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4161\/hv.8.1.18808","article-title":"Ten lessons for the next influenza pandemic-an English perspective: a personal reflection based on community surveillance data","volume":"8","author":"Fleming","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"17","key":"10.1016\/j.vaccine.2013.02.033_bib0015","first-page":"467","article-title":"Outbreak of swine-origin influenza A (H1N1) virus infection \u2013 Mexico, March\u2013April 2009","volume":"58","author":"Centers for Disease C, Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.033_bib0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3201\/eid1506.090072","article-title":"Past, present, and possible future human infection with influenza virus A subtype H7","volume":"15","author":"Belser","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0025","unstructured":"World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003\u20132012. Available from: http:\/\/www.who.int\/influenza\/human_animal_interface\/EN_GIP_20120402CumulativeNumberH5N1cases.pdf; April 2, 2012 [accessed 13.12.12]."},{"issue":"15","key":"10.1016\/j.vaccine.2013.02.033_bib0030","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","article-title":"Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring","volume":"27","author":"Vellozzi","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.033_bib0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"9587","key":"10.1016\/j.vaccine.2013.02.033_bib0040","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2013.02.033_bib0045","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1010331","article-title":"Oil-in-water emulsion adjuvant with influenza vaccine in young children","volume":"365","author":"Vesikari","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.033_bib0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.clpt.6100415","article-title":"Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics","volume":"82","author":"Poland","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2013.02.033_bib0055","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of vaccination for seasonal influenza in humans","volume":"12","author":"Nakaya","year":"2011","journal-title":"Nat Immunol"},{"issue":"51","key":"10.1016\/j.vaccine.2013.02.033_bib0060","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1016\/j.vaccine.2012.09.083","article-title":"Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine","volume":"30","author":"Maraskovsky","year":"2012","journal-title":"Vaccine"},{"issue":"4 Suppl.","key":"10.1016\/j.vaccine.2013.02.033_bib0065","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/CCM.0b013e3181d44c1e","article-title":"Hark back: passive immunotherapy for influenza and other serious infections","volume":"38","author":"Luke","year":"2010","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0070","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/CCM.0b013e318236f486","article-title":"The use of hyperimmune serum for severe influenza infections*","volume":"40","author":"Rockman","year":"2012","journal-title":"Crit Care Med"},{"issue":"14","key":"10.1016\/j.vaccine.2013.02.033_bib0075","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMc070359","article-title":"Treatment with convalescent plasma for influenza A (H5N1) infection","volume":"357","author":"Zhou","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.033_bib0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.033_bib0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmii.2010.07.001","article-title":"A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G","volume":"44","author":"Chong","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0090","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/cid\/ciq082","article-title":"Pooled human immunoglobulin therapy in critically Ill patients with pandemic 2009 influenza A(H1N1) pneumonitis and immunoglobulin G2 subclass (IgG2) deficiency","volume":"52","author":"Gordon","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.033_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.iac.2008.06.004","article-title":"History of immunoglobulin replacement","volume":"28","author":"Eibl","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"issue":"15","key":"10.1016\/j.vaccine.2013.02.033_bib0100","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1128\/JVI.00241-09","article-title":"Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization","volume":"83","author":"Middleton","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0105","unstructured":"Australian Government Department of Health and Ageing. Australian Influenza Surveillance Summary Report, No. 26, 2009, Reporting Period: 31 October 2009\u20136 November 2009. Available from: http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/cda-ozflu-no26-09.htm [accessed 21.12.12]."},{"key":"10.1016\/j.vaccine.2013.02.033_bib0110","unstructured":"Department of Health and Human Services HP. Healthy People 2020 Summary of objectives: immunization and infectious diseases. Available from: http:\/\/www.healthypeople.gov\/2020\/topicsobjectives2020\/pdfs\/Immunization.pdf [accessed 25.10.12]."},{"issue":"9103","key":"10.1016\/j.vaccine.2013.02.033_bib0115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","article-title":"Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"351","author":"Wakefield","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.033_bib0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJMp1010594","article-title":"The age-old struggle against the antivaccinationists","volume":"364","author":"Poland","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.02.033_bib0125","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1086\/524991","article-title":"Ecology of avian influenza virus in birds","volume":"197","author":"Causey","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.033_bib0130","first-page":"32","article-title":"The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter","volume":"3","author":"Fleming","year":"2000","journal-title":"Commun Dis Public Health"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0135","article-title":"Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999\u20132010","author":"Hardelid","year":"2012","journal-title":"Influenza Other Resp Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.033_bib0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.vaccine.2013.02.033_bib0145","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1017\/S0950268807009910","article-title":"Lessons from 40years\u2019 surveillance of influenza in England and Wales","volume":"136","author":"Fleming","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.033_bib0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918\u20131920 \u201cSpanish\u201d influenza pandemic","volume":"76","author":"Johnson","year":"2002","journal-title":"Bull Hist Med"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.033_bib0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 influenza: the mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.02.033_bib0160","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1086\/514171","article-title":"Perspectives on pandemics: a research agenda","volume":"176","author":"Kilbourne","year":"1997","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2013.02.033_bib0165","first-page":"453","article-title":"Update: novel influenza A (H1N1) virus infections \u2013 worldwide, May 6, 2009","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2013.02.033_bib0170","first-page":"363","article-title":"Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage \u2013 United States, October 2009\u2013January 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0175","unstructured":"World Health Organization. Pandemic (H1N1) 2009 \u2013 update 112. August 6, 2010; Available from: http:\/\/www.who.int\/csr\/don\/2010_08_06\/en\/index.html [accessed 13.12.12]."},{"issue":"9","key":"10.1016\/j.vaccine.2013.02.033_bib0180","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"5745","key":"10.1016\/j.vaccine.2013.02.033_bib0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1119392","article-title":"Characterization of the reconstructed 1918 Spanish influenza pandemic virus","volume":"310","author":"Tumpey","year":"2005","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.033_bib0190","doi-asserted-by":"crossref","first-page":"e00201","DOI":"10.1128\/mBio.00201-12","article-title":"Reconstruction of the 1918 influenza virus: unexpected rewards from the past","volume":"3","author":"Taubenberger","year":"2012","journal-title":"MBio"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMp0904819","article-title":"The persistent legacy of the 1918 influenza virus","volume":"361","author":"Morens","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2013.02.033_bib0200","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0205","unstructured":"World Health Organization. Current WHO phase of pandemic alert (avian influenza H5N1). Available from: http:\/\/www.who.int\/influenza\/preparedness\/pandemic\/h5n1phase\/en\/index.html; 2012 [accessed 13.12.12]."},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.033_bib0210","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.0308352100","article-title":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome","volume":"101","author":"Fouchier","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.033_bib0215","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3201\/eid1805.111852","article-title":"Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia","volume":"18","author":"Arzey","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.033_bib0220","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3201\/eid1805.111922","article-title":"Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011","volume":"18","author":"Lindstrom","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0225","unstructured":"Centers for Disease Control and Prevention. H1N2 Variant Virus Detected in Minnesota. September 7, 2012; Available from: http:\/\/www.cdc.gov\/flu\/spotlights\/h1n2v-cases-mn.htm [accessed 13.12.12]."},{"issue":"16","key":"10.1016\/j.vaccine.2013.02.033_bib0230","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1128\/JVI.00259-12","article-title":"Evolution of novel reassortant A\/H3N2 influenza viruses in North American swine and humans, 2009\u20132011","volume":"86","author":"Nelson","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0235","unstructured":"World Health Organization Department of Public Health and Environment & WASH Inter Agency Group. Questions and Answers on potential transmission of avian influenza (H5N1) through water, Sanitation and Hygiene and ways to reduce the risks to human health. Available from: http:\/\/www.who.int\/water_sanitation_health\/emerging\/AI_WASH_working_group_qas_april_2007.pdf; April 2007 [accessed 17.12.12]."},{"issue":"15","key":"10.1016\/j.vaccine.2013.02.033_bib0240","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1128\/JVI.02677-05","article-title":"Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells","volume":"80","author":"Ibricevic","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0245","series-title":"Influenza","author":"World Health Organization","year":"2012"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0250","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1165\/rcmb.2010-0108OC","article-title":"Innate immune response to influenza A virus in differentiated human alveolar type II cells","volume":"45","author":"Wang","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2013.02.033_bib0255","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/v4091438","article-title":"Evasion of influenza a viruses from innate and adaptive immune responses","volume":"4","author":"van de Sandt","year":"2012","journal-title":"Viruses"},{"issue":"24","key":"10.1016\/j.vaccine.2013.02.033_bib0260","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1056\/NEJMoa055414","article-title":"Effectiveness of school-based influenza vaccination","volume":"355","author":"King","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0265","series-title":"Background paper on influenza vaccines and immunization","author":"World Health Organization","year":"2010"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0270","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3201\/eid0703.017301","article-title":"Seasonal variation in host susceptibility and cycles of certain infectious diseases","volume":"7","author":"Dowell","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.033_bib0275","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.inf.0000109392.96411.4f","article-title":"Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents","volume":"23","author":"Bergen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"13","key":"10.1016\/j.vaccine.2013.02.033_bib0280","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.vaccine.2013.02.033_bib0285","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archinte.1996.00440130090009","article-title":"Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial","volume":"156","author":"Nichol","year":"1996","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.vaccine.2013.02.033_bib0290","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archpedi.158.11.1031","article-title":"Safety of the trivalent inactivated influenza vaccine among children: a population-based study","volume":"158","author":"France","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.033_bib0295","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1750-2659.2011.00243.x","article-title":"An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2\u201317years","volume":"5","author":"Ambrose","year":"2011","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0300","series-title":"Adverse effects of vaccines: evidence and causality","author":"Institute of Medicine","year":"2012"},{"issue":"8","key":"10.1016\/j.vaccine.2013.02.033_bib0305","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00006454-200108000-00004","article-title":"Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985\u20131990: the pediatric experience","volume":"20","author":"Neuzil","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"21","key":"10.1016\/j.vaccine.2013.02.033_bib0310","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.1994.03520210045030","article-title":"The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial","volume":"272","author":"Govaert","year":"1994","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.vaccine.2013.02.033_bib0315","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/cis574","article-title":"Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains","volume":"55","author":"Treanor","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.033_bib0320","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/599790","article-title":"Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65years of age and older","volume":"200","author":"Falsey","year":"2009","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0325","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.033_bib0330","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/588670","article-title":"Genetic basis for adverse events after smallpox vaccination","volume":"198","author":"Reif","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0335","unstructured":"Australian Government Department of Health and Ageing Therapeutic Goods Administration. Overview of Vaccine Regulation and Safety Monitoring and Investigation into Adverse events Following 2010 Seasonal Influenza Vaccination in Young Children. October 8, 2010; Available from: http:\/\/www.tga.gov.au\/pdf\/alerts-medicine-seasonal-flu-101008.pdf [accessed 21.12.12]."},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.033_bib0340","doi-asserted-by":"crossref","first-page":"e000016","DOI":"10.1136\/bmjopen-2010-000016","article-title":"Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine","volume":"1","author":"Armstrong","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0345","unstructured":"ClinicalTrials.gov. Safety study of CSL limited's influenza virus vaccine in the paediatric population aged\u22656months to <18years. Updated August 25, 2011; Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00825162?term=CSL+AND+influenza+AND+vaccine+AN%20D+children&rank=2 [accessed 03.12.12]."},{"key":"10.1016\/j.vaccine.2013.02.033_bib0350","unstructured":"Rockman SBD, Dyson A, et al., in preparation."},{"issue":"8","key":"10.1016\/j.vaccine.2013.02.033_bib0355","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.033_bib0360","first-page":"67","article-title":"Experience in treating influenza with dry anti-influenza serum of Smorodintsev; preliminary report","volume":"20","author":"Berezina","year":"1956","journal-title":"Sov Med"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0365","first-page":"69","article-title":"On the treatment of influenza and influenzal pneumonia","volume":"41","author":"Stavskaia","year":"1963","journal-title":"Klin Med (Mosk)"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0370","first-page":"104","article-title":"Experimental for achievement of therapeutic sera against respiratory infections from immunized donors","volume":"1","author":"Selivanov","year":"1967","journal-title":"Vrach Delo"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0375","first-page":"47","article-title":"Character of the therapeutic action of different schedules of administration of donor anti-influenza gamma-globulin to influenza patients","volume":"63","author":"Zhukova","year":"1985","journal-title":"Tr Inst Im Pastera"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0380","first-page":"52","article-title":"Experience with the clinical use of donor anti-influenza gamma-globulin","volume":"63","author":"Firsov","year":"1985","journal-title":"Tr Inst Im Pastera"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.033_bib0385","first-page":"83","article-title":"Production of passive immunity in neonatal ferrets following maternal vaccination with killed influenza A virus vaccines","volume":"60","author":"Sweet","year":"1987","journal-title":"Immunology"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2013.02.033_bib0390","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1099\/0022-1317-68-10-2681","article-title":"Role of milk-derived IgG in passive maternal protection of neonatal ferrets against influenza","volume":"68","author":"Sweet","year":"1987","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2013.02.033_bib0395","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2746\/042516401776249273","article-title":"Evaluation of IgG concentration and IgG subisotypes in foals with complete or partial failure of passive transfer after administration of intravenous serum or plasma","volume":"33","author":"McClure","year":"2001","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0400","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1465-9921-7-43","article-title":"Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab\u2019)2 in mice","volume":"7","author":"Lu","year":"2006","journal-title":"Respir Res"},{"issue":"11","key":"10.1016\/j.vaccine.2013.02.033_bib0405","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/dna.2005.24.758","article-title":"Maternal immunization with both hemagglutinin- and neuraminidase-expressing DNAs provides an enhanced protection against a lethal influenza virus challenge in infant and adult mice","volume":"24","author":"Zhang","year":"2005","journal-title":"DNA Cell Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.033_bib0410","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1128\/JVI.71.6.4347-4355.1997","article-title":"A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro","volume":"71","author":"Mozdzanowska","year":"1997","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.033_bib0415","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4049\/jimmunol.115.2.434","article-title":"Host defenses against influenza virus: the role of anti-hemagglutinin antibody","volume":"115","author":"Virelizier","year":"1975","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2013.02.033_bib0420","doi-asserted-by":"crossref","first-page":"686","DOI":"10.7326\/0003-4819-146-9-200705010-00020","article-title":"Blood products for Spanish influenza: a future H5N1 treatment?","volume":"146","author":"Logtenberg","year":"2007","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.033_bib0425","first-page":"CS11","article-title":"High dose immune globulin therapy ameliorates peripartum cardiomyopathy with elevated serum antibody titer to influenza virus: case report of two patients","volume":"16","author":"Muroya","year":"2010","journal-title":"Med Sci Monit"},{"issue":"10","key":"10.1016\/j.vaccine.2013.02.033_bib0430","first-page":"639","article-title":"Case of adult influenza type A virus-associated encephalopathy successfully treated with primary multidisciplinary treatments","volume":"47","author":"Sakurai","year":"2007","journal-title":"Rinsho Shinkeigaku"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0435","doi-asserted-by":"crossref","first-page":"295","DOI":"10.11150\/kansenshogakuzasshi.86.295","article-title":"An adult case of influenza-associated encephalitis successfully treated with high dose intravenous immunoglobulins","volume":"86","author":"Iwanaga","year":"2012","journal-title":"Kansenshogaku Zasshi"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.033_bib0440","first-page":"217","article-title":"Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture","volume":"3","author":"Sullivan","year":"2009","journal-title":"J Mol Genet Med"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.033_bib0445","first-page":"201","article-title":"Neutralizing virus antibodies in human immunoglobulins for intravenous use","volume":"12","author":"Weeke-Luttmann","year":"1984","journal-title":"Immun Infekt"},{"issue":"9","key":"10.1016\/j.vaccine.2013.02.033_bib0450","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3201\/eid1509.090471","article-title":"Cross-reactive Antibodies against avian influenza virus A (H5N1)","volume":"15","author":"Pichyangkul","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.033_bib0455","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2141.2009.08016.x","article-title":"Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1","volume":"148","author":"Yunoki","year":"2010","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.033_bib0460","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1537-2995.2011.03347.x","article-title":"Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza","volume":"52","author":"Kreil","year":"2012","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.033_bib0465","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/INF.0b013e3181f127be","article-title":"Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza a virus in intravenous immunoglobulin preparations","volume":"30","author":"Hong","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.033_bib0470","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/AAC.01312-06","article-title":"Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus","volume":"51","author":"Govorkova","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.033_bib0475","article-title":"Fresh frozen plasma for transfusion: a review","volume":"10","author":"Yim","year":"2008","journal-title":"Blood Bullet"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0480","unstructured":"ClinicalTrials.gov. Safety and efficacy of investigational immune plasma in treating influenza A. Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01052480?term=influenza+plasma [accessed 24.10.12]."},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.033_bib0485","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14760584.6.5.761","article-title":"ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines","volume":"6","author":"Drane","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0630","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/JVI.02434-12","article-title":"Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal HN influenza in ferrets immunised with seasonal influenza vaccine","volume":"87","author":"Rockman Steven","year":"2013","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2013.02.033_bib0495","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.ppat.1002344","article-title":"Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?","volume":"7","author":"Poland","year":"2011","journal-title":"PLoS Pathog"},{"issue":"44","key":"10.1016\/j.vaccine.2013.02.033_bib0500","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1016\/j.vaccine.2010.09.045","article-title":"A global prescription for adult immunization: time is catching up with us","volume":"28","author":"Poland","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0505","unstructured":"Federal Interagency Forum on Aging-Related Statistics. Older Americans 2012: key indicators of well-being. June 2012; Available from: http:\/\/agingstats.gov\/Main_Site\/Data\/2006_Documents\/Population.pdf [accessed 21.12.12]."},{"issue":"9","key":"10.1016\/j.vaccine.2013.02.033_bib0510","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/omi.2011.0032","article-title":"Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections","volume":"15","author":"Poland","year":"2011","journal-title":"OMICS"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0515","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1208\/s12248-011-9281-x","article-title":"Vaccinomics: current findings, challenges and novel approaches for vaccine development","volume":"13","author":"Ovsyannikova","year":"2011","journal-title":"AAPS J"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0520","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.coi.2011.04.005","article-title":"Systems biology approaches to new vaccine development","volume":"23","author":"Oberg","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2013.02.033_bib0525","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2217\/fmb.10.146","article-title":"Vaccinomics, predictive vaccinology and the future of vaccine development","volume":"5","author":"Haralambieva","year":"2010","journal-title":"Future Microbiol"},{"issue":"20","key":"10.1016\/j.vaccine.2013.02.033_bib0530","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1016\/j.vaccine.2010.03.031","article-title":"Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology","volume":"28","author":"Poland","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.033_bib0535","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2217\/pgs.09.25","article-title":"Application of pharmacogenomics to vaccines","volume":"10","author":"Poland","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.033_bib0540","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.clpt.6100379","article-title":"Pharmacology, vaccinomics, and the second golden age of vaccinology","volume":"82","author":"Poland","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0545","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jaci.2007.04.036","article-title":"Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors","volume":"120","author":"Dhiman","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2013.02.033_bib0550","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.inf.0000073059.57867.36","article-title":"Measles outbreak in Dublin, 2000","volume":"22","author":"McBrien","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"37","key":"10.1016\/j.vaccine.2013.02.033_bib0555","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1016\/j.vaccine.2011.07.131","article-title":"Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education","volume":"29","author":"Poland","year":"2011","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2013.02.033_bib0560","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/j.vaccine.2009.01.069","article-title":"Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics","volume":"27","author":"Poland","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0565","unstructured":"Centers for Disease Control and Prevention. Healthy people 2010 final review. Immunization and infectious diseases. Available from: http:\/\/www.cdc.gov\/nchs\/data\/hpdata2010\/hp2010_final_review_focus_area_14.pdf [accessed 30.10.12]."},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2013.02.033_bib0570","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-0691.2012.03982.x","article-title":"Measles still spreads in Europe: who is responsible for the failure to vaccinate?","volume":"18","author":"Carrillo-Santisteve","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0575","first-page":"986","article-title":"Mumps outbreak on a university campus \u2013 California, 2011","volume":"61","author":"Centers for Disease C, Prevention.","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0580","series-title":"A whole new mind: why right-brainers will rule the future","author":"Pink","year":"2006"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0585","series-title":"The literary mind","author":"Turner","year":"1996"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0590","series-title":"Amusing ourselves to death","author":"Postman","year":"1985"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0595","series-title":"Thinking, fast and slow","author":"Kahneman","year":"2011"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.033_bib0600","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1037\/a0016830","article-title":"Toward a theory of motivational interviewing","volume":"64","author":"Miller","year":"2009","journal-title":"Am Psychol"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0605","series-title":"Health behavior and health education: theory, research, and practice","first-page":"45","article-title":"The health belief model","author":"Janz","year":"2002"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0610","series-title":"Key facts about seasonal flu vaccine","author":"Centers for Disease Control and Prevention","year":"2012"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.033_bib0615","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/infdis\/168.3.647","article-title":"Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants","volume":"168","author":"Englund","year":"1993","journal-title":"J Infect Dis"},{"issue":"198","key":"10.1016\/j.vaccine.2013.02.033_bib0620","first-page":"7","article-title":"Intrapulmonary BCG cell wall vaccination in mice","volume":"49","author":"Reuman","year":"1987","journal-title":"Microbios"},{"key":"10.1016\/j.vaccine.2013.02.033_bib0625","unstructured":"Department of Health and Human Services Administration on Aging. A Profile of Older Americans: 2003. Available from: http:\/\/www.aoa.gov\/AoAroot\/Aging_Statistics\/Profile\/2003\/4.aspx [accessed 30.08.12]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T02:26:07Z","timestamp":1688178367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13001965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":125,"alternative-id":["S0264410X13001965"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.02.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}